Biologic 0 8 0 8 B-treatment
( 9 10 9 10 I-treatment
anti 10 14 10 14 I-treatment
- 14 15 14 15 I-treatment
neoplastic 15 25 15 25 I-treatment
) 25 26 25 26 I-treatment
agent 27 32 27 32 I-treatment
: 32 33 32 33 O
at 34 36 34 36 O
least 37 42 37 42 O
7 43 44 43 44 B-lower_bound
days 45 49 45 49 I-lower_bound
since 50 55 50 55 O
the 56 59 56 59 O
completion 60 70 60 70 O
of 71 73 71 73 O
therapy 74 81 74 81 B-treatment
with 82 86 82 86 I-treatment
a 87 88 87 88 I-treatment
biologic 89 97 89 97 I-treatment
agent 98 103 98 103 I-treatment

Creatinine 0 10 104 114 B-clinical_variable
clearance 11 20 115 124 I-clinical_variable
or 21 23 125 127 O
radioisotope 24 36 128 140 O
glomerular 37 47 141 151 B-clinical_variable
filtration 48 58 152 162 I-clinical_variable
rate 59 63 163 167 I-clinical_variable
( 64 65 168 169 I-clinical_variable
GFR 65 68 169 172 I-clinical_variable
) 68 69 172 173 I-clinical_variable
> 70 71 174 175 O
= 71 72 175 176 O
70 73 75 177 179 B-lower_bound
mL 76 78 180 182 I-lower_bound
/ 78 79 182 183 I-lower_bound
min/1.73 79 87 183 191 I-lower_bound
m^2 88 91 192 195 I-lower_bound
or 92 94 196 198 O
a 95 96 199 200 O
serum 97 102 201 206 B-clinical_variable
creatinine 103 113 207 217 I-clinical_variable
based 114 119 218 223 O
on 120 122 224 226 O
age 123 126 227 230 B-age
/ 126 127 230 231 O
gender 127 133 231 237 O

Cytotoxic 0 9 238 247 B-treatment
therapy 10 17 248 255 I-treatment
: 17 18 255 256 O
at 19 21 257 259 O
least 22 27 260 265 O
14 28 30 266 268 B-lower_bound
days 31 35 269 273 I-lower_bound
since 36 41 274 279 O
the 42 45 280 283 O
completion 46 56 284 294 O
of 57 59 295 297 O
cytotoxic 60 69 298 307 B-treatment
therapy 70 77 308 315 I-treatment
with 78 82 316 320 O
the 83 86 321 324 O
exception 87 96 325 334 O
of 97 99 335 337 O
hydroxyurea 100 111 338 349 B-chronic_disease
, 111 112 349 350 O
which 113 118 351 356 O
is 119 121 357 359 O
permitted 122 131 360 369 O
up 132 134 370 372 O
to 135 137 373 375 O
24 138 140 376 378 B-upper_bound
hours 141 146 379 384 I-upper_bound
prior 147 152 385 390 I-upper_bound
to 153 155 391 393 O
the 156 159 394 397 O
start 160 165 398 403 O
of 166 168 404 406 O
protocol 169 177 407 415 O
therapy 178 185 416 423 O
, 185 186 423 424 O
or 187 189 425 427 O
maintenance 190 201 428 439 B-treatment
chemotherapy 202 214 440 452 I-treatment
, 214 215 452 453 O
or 216 218 454 456 O
intrathecal 219 230 457 468 B-treatment
chemotherapy 231 243 469 481 I-treatment
( 244 245 482 483 O
methotrexate 245 257 483 495 B-treatment
strongly 258 266 496 504 O
preferred 267 276 505 514 O
) 276 277 514 515 O
administered 278 290 516 528 O
at 291 293 529 531 O
the 294 297 532 535 O
time 298 302 536 540 O
of 303 305 541 543 O
the 306 309 544 547 O
required 310 318 548 556 O
diagnostic 319 329 557 567 O
lumbar 330 336 568 574 O
puncture 337 345 575 583 O
to 346 348 584 586 O
establish 349 358 587 596 O
baseline 359 367 597 605 O
CNS 368 371 606 609 O
status 372 378 610 616 O

Direct 0 6 617 623 B-clinical_variable
bilirubin 7 16 624 633 I-clinical_variable
< 17 18 634 635 O
3.0 19 22 636 639 B-upper_bound
mg 23 25 640 642 I-upper_bound
/ 25 26 642 643 I-upper_bound
dL 26 28 643 645 I-upper_bound

Ejection 0 8 646 654 B-clinical_variable
fraction 9 17 655 663 I-clinical_variable
of 18 20 664 666 O
> 21 22 667 668 O
= 22 23 668 669 O
50 24 26 670 672 B-lower_bound
% 26 27 672 673 I-lower_bound
by 28 30 674 676 O
radionuclide 31 43 677 689 B-treatment
angiogram 44 53 690 699 I-treatment

First 0 5 700 705 O
relapse 6 13 706 713 O
of 14 16 714 716 O
B 17 18 717 718 B-cancer
- 18 19 718 719 I-cancer
ALL 19 22 719 722 I-cancer
, 22 23 722 723 O
allowable 24 33 724 733 O
sites 34 39 734 739 O
of 40 42 740 742 O
disease 43 50 743 750 O
include 51 58 751 758 O
isolated 59 67 759 767 O
bone 68 72 768 772 O
marrow 73 79 773 779 O
, 79 80 779 780 O
combined 81 89 781 789 O
bone 90 94 790 794 O
marrow 95 101 795 801 O
and 102 105 802 805 O
CNS 106 109 806 809 O
and/or 110 116 810 816 O
testicular 117 127 817 827 O
, 127 128 827 828 O
and 129 132 829 832 O
isolated 133 141 833 841 O
CNS 142 145 842 845 O
and/or 146 152 846 852 O
testicular 153 163 853 863 O
; 163 164 863 864 O
extramedullary 165 179 865 879 O
sites 180 185 880 885 O
are 186 189 886 889 O
limited 190 197 890 897 O
to 198 200 898 900 O
the 201 204 901 904 O
CNS 205 208 905 908 O
and 209 212 909 912 O
testicles 213 222 913 922 O

Lactating 0 9 923 932 O
females 10 17 933 940 B-gender
who 18 21 941 944 O
plan 22 26 945 949 O
to 27 29 950 952 O
breastfeed 30 40 953 963 O

No 0 2 964 966 O
waiting 3 10 967 974 O
period 11 17 975 981 O
for 18 21 982 985 O
patients 22 30 986 994 O
who 31 34 995 998 O
relapse 35 42 999 1006 O
while 43 48 1007 1012 O
receiving 49 58 1013 1022 O
standard 59 67 1023 1031 B-treatment
maintenance 68 79 1032 1043 I-treatment
therapy 80 87 1044 1051 I-treatment

Patient 0 7 1052 1059 O
has 8 11 1060 1063 O
not 12 15 1064 1067 O
had 16 19 1068 1071 O
prior 20 25 1072 1077 B-treatment
treatment 26 35 1078 1087 I-treatment
with 36 40 1088 1092 O
blinatumomab 41 53 1093 1105 B-treatment

Patients 0 8 1106 1114 O
known 9 14 1115 1120 O
to 15 17 1121 1123 O
have 18 22 1124 1128 O
one 23 26 1129 1132 O
of 27 29 1133 1135 O
the 30 33 1136 1139 O
following 34 43 1140 1149 O
concomitant 44 55 1150 1161 B-chronic_disease
genetic 56 63 1162 1169 I-chronic_disease
syndromes 64 73 1170 1179 I-chronic_disease
: 73 74 1179 1180 O
Down 75 79 1181 1185 B-chronic_disease
syndrome 80 88 1186 1194 I-chronic_disease
, 88 89 1194 1195 O
Bloom 90 95 1196 1201 B-chronic_disease
syndrome 96 104 1202 1210 I-chronic_disease
, 104 105 1210 1211 O
ataxia 106 112 1212 1218 B-chronic_disease
- 112 113 1218 1219 I-chronic_disease
telangiectasia 113 127 1219 1233 I-chronic_disease
, 127 128 1233 1234 O
Fanconi 129 136 1235 1242 B-chronic_disease
anemia 137 143 1243 1249 I-chronic_disease
, 143 144 1249 1250 O
Kostmann 145 153 1251 1259 B-chronic_disease
syndrome 154 162 1260 1268 I-chronic_disease
, 162 163 1268 1269 O
Shwachman 164 173 1270 1279 B-chronic_disease
syndrome 174 182 1280 1288 I-chronic_disease
or 183 185 1289 1291 O
any 186 189 1292 1295 O
other 190 195 1296 1301 O
known 196 201 1302 1307 O
bone 202 206 1308 1312 B-chronic_disease
marrow 207 213 1313 1319 I-chronic_disease
failure 214 221 1320 1327 I-chronic_disease
syndrome 222 230 1328 1336 I-chronic_disease

Patients 0 8 1337 1345 O
must 9 13 1346 1350 O
have 14 18 1351 1355 O
a 19 20 1356 1357 O
performance 21 32 1358 1369 O
status 33 39 1370 1376 O
corresponding 40 53 1377 1390 O
to 54 56 1391 1393 O
Eastern 57 64 1394 1401 B-clinical_variable
Cooperative 65 76 1402 1413 I-clinical_variable
Oncology 77 85 1414 1422 I-clinical_variable
Group 86 91 1423 1428 I-clinical_variable
( 92 93 1429 1430 I-clinical_variable
ECOG 93 97 1430 1434 I-clinical_variable
) 97 98 1434 1435 I-clinical_variable
scores 99 105 1436 1442 I-clinical_variable
of 106 108 1443 1445 O
0 109 110 1446 1447 B-lower_bound
, 110 111 1447 1448 O
1 112 113 1449 1450 O
, 113 114 1450 1451 O
or 115 117 1452 1454 O
2 118 119 1455 1456 B-upper_bound

Patients 0 8 1457 1465 O
who 9 12 1466 1469 O
are 13 16 1470 1473 O
pregnant 17 25 1474 1482 B-pregnancy
since 26 31 1483 1488 O
fetal 32 37 1489 1494 O
toxicities 38 48 1495 1505 O
and 49 52 1506 1509 O
teratogenic 53 64 1510 1521 O
effects 65 72 1522 1529 O
have 73 77 1530 1534 O
been 78 82 1535 1539 O
noted 83 88 1540 1545 O
for 89 92 1546 1549 O
several 93 100 1550 1557 O
of 101 103 1558 1560 O
the 104 107 1561 1564 O
study 108 113 1565 1570 O
drugs 114 119 1571 1576 O
; 119 120 1576 1577 O
a 121 122 1578 1579 O
pregnancy 123 132 1580 1589 B-pregnancy
test 133 137 1590 1594 O
is 138 140 1595 1597 O
required 141 149 1598 1606 O
for 150 153 1607 1610 O
female 154 160 1611 1617 B-gender
patients 161 169 1618 1626 I-gender
of 170 172 1627 1629 O
childbearing 173 185 1630 1642 O
potential 186 195 1643 1652 O

Patients 0 8 1653 1661 O
who 9 12 1662 1665 O
relapse 13 20 1666 1673 O
on 21 23 1674 1676 O
frontline 24 33 1677 1686 O
therapy 34 41 1687 1694 B-treatment
in 42 44 1695 1697 O
phases 45 51 1698 1704 O
other 52 57 1705 1710 O
than 58 62 1711 1715 O
maintenance 63 74 1716 1727 O
must 75 79 1728 1732 O
have 80 84 1733 1737 O
fully 85 90 1738 1743 O
recovered 91 100 1744 1753 O
from 101 105 1754 1758 O
the 106 109 1759 1762 O
acute 110 115 1763 1768 O
toxic 116 121 1769 1774 O
effects 122 129 1775 1782 O
of 130 132 1783 1785 O
all 133 136 1786 1789 O
prior 137 142 1790 1795 B-treatment
chemotherapy 143 155 1796 1808 I-treatment
, 155 156 1808 1809 O
immunotherapy 157 170 1810 1823 B-treatment
, 170 171 1823 1824 O
or 172 174 1825 1827 O
radiotherapy 175 187 1828 1840 B-treatment
prior 188 193 1841 1846 I-treatment
to 194 196 1847 1849 O
entering 197 205 1850 1858 O
this 206 210 1859 1863 O
study 211 216 1864 1869 O

Patients 0 8 1870 1878 O
with 9 13 1879 1883 O
B 14 15 1884 1885 B-cancer
- 15 16 1885 1886 I-cancer
lymphoblastic 16 29 1886 1899 I-cancer
lymphoma 30 38 1900 1908 I-cancer
( 39 40 1909 1910 I-cancer
B 40 41 1910 1911 I-cancer
- 41 42 1911 1912 I-cancer
LL 42 44 1912 1914 I-cancer
) 44 45 1914 1915 I-cancer

Patients 0 8 1916 1924 O
with 9 13 1925 1929 O
Burkitt 14 21 1930 1937 B-cancer
leukemia 22 30 1938 1946 I-cancer
/ 30 31 1946 1947 O
lymphoma 31 39 1947 1955 B-cancer
or 40 42 1956 1958 O
mature 43 49 1959 1965 B-cancer
B 50 51 1966 1967 I-cancer
- 51 52 1967 1968 I-cancer
cell 52 56 1968 1972 I-cancer
leukemia 57 65 1973 1981 I-cancer

Patients 0 8 1982 1990 O
with 9 13 1991 1995 O
Philadelphia 14 26 1996 2008 B-cancer
chromosome 27 37 2009 2019 I-cancer
positive 38 46 2020 2028 I-cancer
/ 46 47 2028 2029 O
breakpoint 47 57 2029 2039 B-cancer
cluster 58 65 2040 2047 I-cancer
region 66 72 2048 2054 I-cancer
protein 73 80 2055 2062 I-cancer
( 81 82 2063 2064 I-cancer
BCR)-Abelson 82 94 2064 2076 I-cancer
murine 95 101 2077 2083 I-cancer
leukemia 102 110 2084 2092 I-cancer
viral 111 116 2093 2098 I-cancer
oncogene 117 125 2099 2107 I-cancer
homolog 126 133 2108 2115 I-cancer
1 134 135 2116 2117 I-cancer
( 136 137 2118 2119 I-cancer
ABL1)+ 137 143 2119 2125 I-cancer
ALL 144 147 2126 2129 O

Patients 0 8 2130 2138 O
with 9 13 2139 2143 O
T 14 15 2144 2145 B-cancer
- 15 16 2145 2146 I-cancer
lymphoblastic 16 29 2146 2159 I-cancer
leukemia 30 38 2160 2168 I-cancer
( 39 40 2169 2170 I-cancer
T 40 41 2170 2171 I-cancer
- 41 42 2171 2172 I-cancer
ALL)/lymphoblastic 42 60 2172 2190 I-cancer
lymphoma 61 69 2191 2199 I-cancer
( 70 71 2200 2201 I-cancer
T 71 72 2201 2202 I-cancer
- 72 73 2202 2203 I-cancer
LL 73 75 2203 2205 I-cancer
) 75 76 2205 2206 I-cancer

Patients 0 8 2207 2215 O
with 9 13 2216 2220 O
known 14 19 2221 2226 O
allergy 20 27 2227 2234 O
to 28 30 2235 2237 O
mitoxantrone 31 43 2238 2250 B-allergy_name
, 43 44 2250 2251 O
cytarabine 45 55 2252 2262 B-allergy_name
, 55 56 2262 2263 O
or 57 59 2264 2266 O
both 60 64 2267 2271 B-allergy_name
etoposide 65 74 2272 2281 I-allergy_name
and 75 78 2282 2285 I-allergy_name
etoposide 79 88 2286 2295 I-allergy_name
phosphate 89 98 2296 2305 I-allergy_name
( 99 100 2306 2307 I-allergy_name
Etopophos 100 109 2307 2316 I-allergy_name
) 109 110 2316 2317 I-allergy_name

Patients 0 8 2318 2326 O
with 9 13 2327 2331 O
known 14 19 2332 2337 O
human 20 25 2338 2343 O
immunodeficiency 26 42 2344 2360 B-chronic_disease
virus 43 48 2361 2366 I-chronic_disease
( 49 50 2367 2368 I-chronic_disease
HIV 50 53 2368 2371 I-chronic_disease
) 53 54 2371 2372 I-chronic_disease
infection 55 64 2373 2382 O

Patients 0 8 2383 2391 O
with 9 13 2392 2396 O
known 14 19 2397 2402 O
optic 20 25 2403 2408 B-chronic_disease
nerve 26 31 2409 2414 I-chronic_disease
and/or 32 38 2415 2421 O
retinal 39 46 2422 2429 O
involvement 47 58 2430 2441 O

Patients 0 8 2442 2450 O
with 9 13 2451 2455 O
pre 14 17 2456 2459 O
- 17 18 2459 2460 O
existing 18 26 2460 2468 O
significant 27 38 2469 2480 O
central 39 46 2481 2488 O
nervous 47 54 2489 2496 O
system 55 61 2497 2503 O
pathology 62 71 2504 2513 O
that 72 76 2514 2518 O
would 77 82 2519 2524 O
preclude 83 91 2525 2533 O
treatment 92 101 2534 2543 B-treatment
with 102 106 2544 2548 I-treatment
blinatumomab 107 119 2549 2561 I-treatment
, 119 120 2561 2562 O
including 121 130 2563 2572 O
: 130 131 2572 2573 O
history 132 139 2574 2581 O
of 140 142 2582 2584 O
severe 143 149 2585 2591 B-chronic_disease
brain 150 155 2592 2597 I-chronic_disease
injury 156 162 2598 2604 I-chronic_disease
, 162 163 2604 2605 O
dementia 164 172 2606 2614 B-chronic_disease
, 172 173 2614 2615 O
cerebellar 174 184 2616 2626 B-chronic_disease
disease 185 192 2627 2634 I-chronic_disease
, 192 193 2634 2635 O
organic 194 201 2636 2643 B-chronic_disease
brain 202 207 2644 2649 I-chronic_disease
syndrome 208 216 2650 2658 I-chronic_disease
, 216 217 2658 2659 O
psychosis 218 227 2660 2669 B-chronic_disease
, 227 228 2669 2670 O
coordination 229 241 2671 2683 B-chronic_disease
/ 241 242 2683 2684 O
movement 242 250 2684 2692 B-chronic_disease
disorder 251 259 2693 2701 I-chronic_disease
, 259 260 2701 2702 O
or 261 263 2703 2705 O
autoimmune 264 274 2706 2716 B-chronic_disease
disease 275 282 2717 2724 I-chronic_disease
with 283 287 2725 2729 O
CNS 288 291 2730 2733 O
involvement 292 303 2734 2745 O

Patients 0 8 2746 2754 O
with 9 13 2755 2759 O
uncontrolled 14 26 2760 2772 O
seizure 27 34 2773 2780 B-chronic_disease
disorder 35 43 2781 2789 I-chronic_disease

Sexually 0 8 2790 2798 O
active 9 15 2799 2805 O
patients 16 24 2806 2814 O
of 25 27 2815 2817 O
reproductive 28 40 2818 2830 O
potential 41 50 2831 2840 O
who 51 54 2841 2844 O
have 55 59 2845 2849 O
not 60 63 2850 2853 B-contraception_consent
agreed 64 70 2854 2860 I-contraception_consent
to 71 73 2861 2863 I-contraception_consent
use 74 77 2864 2867 I-contraception_consent
an 78 80 2868 2870 I-contraception_consent
effective 81 90 2871 2880 I-contraception_consent
contraceptive 91 104 2881 2894 I-contraception_consent
method 105 111 2895 2901 I-contraception_consent
for 112 115 2902 2905 O
the 116 119 2906 2909 O
duration 120 128 2910 2918 O
of 129 131 2919 2921 O
their 132 137 2922 2927 O
study 138 143 2928 2933 O
participation 144 157 2934 2947 O

Shortening 0 10 2948 2958 B-clinical_variable
fraction 11 19 2959 2967 I-clinical_variable
of 20 22 2968 2970 O
> 23 24 2971 2972 O
= 24 25 2972 2973 O
27 26 28 2974 2976 B-lower_bound
% 28 29 2976 2977 I-lower_bound
by 30 32 2978 2980 O
echocardiogram 33 47 2981 2995 B-treatment

Stem 0 4 2996 3000 B-treatment
cell 5 9 3001 3005 I-treatment
transplant 10 20 3006 3016 I-treatment
or 21 23 3017 3019 O
rescue 24 30 3020 3026 O
: 30 31 3026 3027 O
patient 32 39 3028 3035 O
has 40 43 3036 3039 O
not 44 47 3040 3043 O
had 48 51 3044 3047 O
a 52 53 3048 3049 O
prior 54 59 3050 3055 B-treatment
stem 60 64 3056 3060 I-treatment
cell 65 69 3061 3065 I-treatment
transplant 70 80 3066 3076 I-treatment
or 81 83 3077 3079 O
rescue 84 90 3080 3086 O

With 0 4 3087 3091 O
the 5 8 3092 3095 O
exception 9 18 3096 3105 O
of 19 21 3106 3108 O
intrathecal 22 33 3109 3120 B-treatment
chemotherapy 34 46 3121 3133 I-treatment
( 47 48 3134 3135 O
methotrexate 48 60 3135 3147 B-treatment
strongly 61 69 3148 3156 O
preferred 70 79 3157 3166 O
; 79 80 3166 3167 O
cytarabine 81 91 3168 3178 B-treatment
is 92 94 3179 3181 O
permissible 95 106 3182 3193 O
) 106 107 3193 3194 O
administered 108 120 3195 3207 O
at 121 123 3208 3210 O
the 124 127 3211 3214 O
time 128 132 3215 3219 O
of 133 135 3220 3222 O
the 136 139 3223 3226 O
required 140 148 3227 3235 O
diagnostic 149 159 3236 3246 O
lumbar 160 166 3247 3253 O
puncture 167 175 3254 3262 O
to 176 178 3263 3265 O
establish 179 188 3266 3275 O
baseline 189 197 3276 3284 O
CNS 198 201 3285 3288 O
status 202 208 3289 3295 O
, 208 209 3295 3296 O
patient 210 217 3297 3304 O
has 218 221 3305 3308 O
not 222 225 3309 3312 O
received 226 234 3313 3321 O
prior 235 240 3322 3327 O
relapse 241 248 3328 3335 O
- 248 249 3335 3336 O
directed 249 257 3336 3344 O
therapy 258 265 3345 3352 O
( 266 267 3353 3354 O
i.e. 267 271 3354 3358 O
, 271 272 3358 3359 O
this 273 277 3360 3364 O
protocol 278 286 3365 3373 O
is 287 289 3374 3376 O
intended 290 298 3377 3385 O
as 299 301 3386 3388 O
the 302 305 3389 3392 O
INITIAL 306 313 3393 3400 O
treatment 314 323 3401 3410 B-treatment
of 324 326 3411 3413 O
first 327 332 3414 3419 O
relapse 333 340 3420 3427 O
) 340 341 3427 3428 O

patients 0 8 3429 3437 O
with 9 13 3438 3442 O
a 14 15 3443 3444 O
history 16 23 3445 3452 O
of 24 26 3453 3455 O
cerebrovascular 27 42 3456 3471 B-chronic_disease
ischemia 43 51 3472 3480 I-chronic_disease
/ 51 52 3480 3481 O
hemorrhage 52 62 3481 3491 B-chronic_disease
with 63 67 3492 3496 O
residual 68 76 3497 3505 O
deficits 77 85 3506 3514 O

patients 0 8 3515 3523 O
with 9 13 3524 3528 O
seizure 14 21 3529 3536 B-chronic_disease
disorders 22 31 3537 3546 I-chronic_disease
that 32 36 3547 3551 O
do 37 39 3552 3554 O
not 40 43 3555 3558 O
require 44 51 3559 3566 O
antiepileptic 52 65 3567 3580 B-treatment
drugs 66 71 3581 3586 I-treatment
, 71 72 3586 3587 O
or 73 75 3588 3590 O
are 76 79 3591 3594 O
well 80 84 3595 3599 O
controlled 85 95 3600 3610 O
with 96 100 3611 3615 O
stable 101 107 3616 3622 O
doses 108 113 3623 3628 O
of 114 116 3629 3631 O
antiepileptic 117 130 3632 3645 O
drugs 131 136 3646 3651 O

use 0 3 3652 3655 O
Karnofsky 4 13 3656 3665 B-clinical_variable
for 14 17 3666 3669 O
patients 18 26 3670 3678 O
> 27 28 3679 3680 O
16 29 31 3681 3683 O
years 32 37 3684 3689 O
of 38 40 3690 3692 O
age 41 44 3693 3696 B-age
and 45 48 3697 3700 O
Lansky 49 55 3701 3707 B-clinical_variable
for 56 59 3708 3711 O
patients 60 68 3712 3720 O
= 69 70 3721 3722 O
< 70 71 3722 3723 O
16 72 74 3724 3726 O
years 75 80 3727 3732 O
of 81 83 3733 3735 O
age 84 87 3736 3739 O

